|
1.
|
Weigelt B, Peterse JL and van ‘t Veer LJ:
Breast cancer metastasis: markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Smirnov DA, Zweitzig DR, Foulk BW, Miller
MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno
JG, Connelly MC, Terstappen LW and O’Hara SM: Global gene
expression profiling of circulating tumor cells. Cancer Res.
65:4993–4997. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor
cells: a novel prognostic factor for newly diagnosed metastatic
breast cancer. J Clin Oncol. 23:1420–1430. 2005. View Article : Google Scholar
|
|
5.
|
Sieuwerts AM, Mostert B, Bolt-de Vries J,
et al: mRNA and microRNA expression profiles in circulating tumor
cells and primary tumors of metastatic breast cancer patients. Clin
Cancer Res. 17:3600–3618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Smid M, Wang Y, Klijn JG, Sieuwerts AM,
Zhang Y, Atkins D, Martens JW and Foekens JA: Genes associated with
breast cancer metastatic to bone. J Clin Oncol. 24:2261–2267. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kang Y, Siegel PM, Shu W, Drobnjak M,
Kakonen SM, Cordón-Cardo C, Guise TA and Massagué J: A multigenic
program mediating breast cancer metastasis to bone. Cancer Cell.
3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bos PD, Zhang XH, Nadal C, Shu W, Gomis
RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA and
Massagué J: Genes that mediate breast cancer metastasis to the
brain. Nature. 459:1005–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Saloustros E, Perraki M, Apostolaki S,
Kallergi G, Xyrafas A, Kalbakis K, Agelaki S, Kalykaki A,
Georgoulias V and Mavroudis D: Cytokeratin-19 mRNA-positive
circulating tumor cells during follow-up of patients with operable
breast cancer: prognostic relevance for late relapse. Breast Cancer
Research. 13:R602011. View
Article : Google Scholar
|
|
11.
|
Reinholz MM, Nibbe A, Jonart LM, Kitzmann
K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC and Lingle
WL: Evaluation of a panel of tumor markers for molecular detection
of circulating cancer cells in women with suspected breast cancer.
Clin Cancer Res. 11:3722–3732. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Speirs V: Oestrogen receptor beta in
breast cancer: good, bad or still too early to tell? J Pathol.
197:143–147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lee GS, Choi KC, Kim HJ and Jeung EB:
Effect of genistein as a selective estrogen receptor beta agonist
on the expression of calbindin-D9k in the uterus of immature rats.
Toxicological Sci. 82:451–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Hartman J, Ström A and Gustafsson JA:
Estrogen receptor beta in breast cancer - diagnostic and
therapeutic implications. Steroids. 74:635–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar
|
|
16.
|
O’Hara SM, Moreno JG, Zweitzig DR, Gross
S, Gomella LG and Terstappen LW: Multigene reverse
transcription-PCR profiling of circulating tumor cells in
hormone-refractory prostate cancer. Clin Chem. 50:826–835.
2004.PubMed/NCBI
|
|
17.
|
Ring AE, Zabaglo L, Ormerod MG, Smith IE
and Dowsett M: Detection of circulating epithelial cells in the
blood of patients with breast cancer: comparison of three
techniques. Br J Cancer. 92:906–912. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Ghadersohi A and Sood AK: Prostate
epithelium-derived Ets transcription factor mRNA is overexpressed
in human breast tumors and is a candidate breast tumor marker and a
breast tumor antigen. Clin Cancer Res. 7:2731–2738. 2001.
|
|
19.
|
Ignatiadis M, Kallergi G, Ntoulia M,
Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E,
Lianidou E, Georgoulias V and Mavroudis D: Prognostic value of the
molecular detection of circulating tumor cells using a multi-marker
reverse transcription-PCR assay for cytokeratin 19, mammaglobin A,
and HER2 in early breast cancer. Clin Cancer Res. 14:2593–2600.
2008. View Article : Google Scholar
|
|
20.
|
Xenidis N, Ignatiadis M, Apostolaki S,
Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G,
Lianidou E, Kakolyris S, Georgoulias V and Mavroudis D:
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant
chemotherapy in patients with early breast cancer. J Clin Oncol.
27:2177–2184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Knowlden JM, Gee JM, Robertson JF, Ellis
IO and Nicholson RI: A possible divergent role for the oestrogen
receptor alpha and beta subtypes in clinical breast cancer. Int J
Cancer. 89:209–212. 2000. View Article : Google Scholar : PubMed/NCBI
|
